Steris | STE - Nettoeinkommen

Aktienkurs
221.80
Täglich Wechseln
-1.72 -0.77%
Monatlich
-0.71%
Jährlich
-1.42%
Q2 Prognose
217.05




Nettoeinkommen Veränderung Datum
3M USD 653M 76M 2026-03
Accuray USD 2.54M 6.49M 2024-12
Avanos Medical USD -1.3M 100K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
CONMED USD 16.74M 13.88M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Ecolab USD 563.9M 21.1M 2025-12
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Fortive USD 185.7M 130.7M 2025-12
Getinge SEK 662M 661M 2024-12
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Idexx Laboratories USD 248.19M 26.42M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Masimo USD 68.3M 168.7M 2025-12
Olympus JPY 14.17B 6.03B 2025-12
Orthofix International USD -2.22M 20.57M 2025-12
Owens Minor USD -56.33M 93.95M 2025-12
ResMed USD 392.59M 44.06M 2025-12
Steris USD 192.9M 1000K 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12